Doxasozin Gastrointestinal Therapeutic System (GITS)

Doxasozin Gastrointestinal Therapeutic System · Pfizer / Upjohn merger with Mylan to Viatris Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Doxasozin Gastrointestinal Therapeutic System (GITS), covering 2021-01-29 to 2021-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement [Phase 4]

See pricing